As the world's leading provider of generic drugs, Actav is Indonesia understands the importance of making safe, quality medications accessible and affordable.
With a portfolio of more than 1,800 molecules, Actavis produces a wide range of generic products in nearly every therapeutic area and format, from tablets and capsules to liquids, ointments and creams, to a broad range of effective dosage forms and complex delivery systems.
Actavis produces 120 billion tablets and capsules a year in 80 manufacturing facilities around the world. With a leadership position (top 3) in 40 markets around the world, the scale and breadth of our generic’s portfolio has an unprecedented impact on global healthcare.
Building on a long track record of achievement, Actavis continues to pursue a strong future in generics as we focus on patient needs, ensuring compliance, convenience, efficacy and safety, and providing affordable generic products to patients and health systems worldwide.
View our Frequently Asked Questions about Generic Medicines